(Total Views: 508)
Posted On: 11/15/2022 6:26:16 PM
Post# of 22465
Here let me make it perfectly clear for you so no glasses will be needed.
No Pasaca,, QMC still revoked BROKE with absolutely NO CHANCE for shareholders to recoup anything.
With Pasaca, in the end you may end up getting diluted but those shares will still be worth a lot more then they were before the company was revoked.
Now I am not even suggesting what happen to Innova (remember they were selling their test at only 5 bucks) will happen to QMC, but what kind of market cap would a company have if they were providing the WORLD with
"a wide menu of testing that includes Sepsis, COVID,
Long-COVID, UTI, and TBI in qualitative, semiquantitative and quantitative resolutions."
because it sure appears they are working towards that goal.
With the "Real Evidence" before us
- hiring of Tony Podesa to lobby " Issues related to manufacturing and design of nanotechnology that pertain to point of care and home based Covid testing". To the Natl Institutes of Health (NIH), Centers For Disease Control Prevention (CDC) and Executive Office of the President (EOP)..
https://projects.propublica.org/represent/lob.../301036564
agreement with Lawson Health Research Institute for the exclusive rights to novel blood biomarkers that characterize Long COVID disease.
- partnership with Neurolytixs (TBI biomarkers)
- vac-check
- quantum dot markers anti-counterfeiting moving forward.
- 5 new patent applications
no glasses of any color are needed to see the possibilities that exist for current shareholders.
No Pasaca,, QMC still revoked BROKE with absolutely NO CHANCE for shareholders to recoup anything.
With Pasaca, in the end you may end up getting diluted but those shares will still be worth a lot more then they were before the company was revoked.
Now I am not even suggesting what happen to Innova (remember they were selling their test at only 5 bucks) will happen to QMC, but what kind of market cap would a company have if they were providing the WORLD with
"a wide menu of testing that includes Sepsis, COVID,
Long-COVID, UTI, and TBI in qualitative, semiquantitative and quantitative resolutions."
because it sure appears they are working towards that goal.
With the "Real Evidence" before us
- hiring of Tony Podesa to lobby " Issues related to manufacturing and design of nanotechnology that pertain to point of care and home based Covid testing". To the Natl Institutes of Health (NIH), Centers For Disease Control Prevention (CDC) and Executive Office of the President (EOP)..
https://projects.propublica.org/represent/lob.../301036564
agreement with Lawson Health Research Institute for the exclusive rights to novel blood biomarkers that characterize Long COVID disease.
- partnership with Neurolytixs (TBI biomarkers)
- vac-check
- quantum dot markers anti-counterfeiting moving forward.
- 5 new patent applications
no glasses of any color are needed to see the possibilities that exist for current shareholders.
(0)
(0)
